Lastly, although we investigated the involvement of the JAK‐STAT signaling pathway and its modulation as a potential therapeutic strategy in our study, the effectiveness and applicability of such interventions may differ between the hematoma model and clinical hemorrhagic stroke. The gene discussed is SOAT1; the disease is hemorrhagic stroke.